Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.6B | 3.4B | 3.9B | 3.7B |
Cost of revenue | 2.2B | 2.1B | 2.3B | 2.2B |
Gross profit | 1.4B | 1.3B | 1.6B | 1.5B |
Operating expense | ||||
Research & development | 559M | 544M | 476M | 509M |
Selling general and admin | 376M | 395M | 393M | 390M |
Other operating expenses | 159M | 149M | 245M | 83M |
Operating income | 319M | 318M | 473M | 519M |
Non operating interest income | ||||
Income | 19M | 27M | -8M | 21M |
Expense | 47M | 44M | 49M | 51M |
Other income expense | — | — | — | — |
Pretax income | 293M | 303M | 448M | 492M |
Tax provision | 63M | 60M | 64M | 88M |
Net income | 232M | 246M | -83M | 403M |
Basic EPS | — | 0.2 | -0.1 | 0.3 |
Diluted EPS | — | 0.2 | -0.1 | 0.3 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 823M | 834M | 970M | 1.0B |
Net income from continuing op. | 230M | 243M | 384M | 404M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 29M | 0 |